A Novel Target Molecule of Nobiletin Derived from Citrus Peels has a Therapeutic Potency Against the Development of Heart Failure
Eur Cardiol
.
2017 Dec;12(2):105.
doi: 10.15420/ecr.2017:23:14.
Authors
Yoichi Sunagawa
1
,
Masafumi Funamoto
1
,
Anna Suzuki
1
,
Kana Shimizu
1
,
Ryoga Sakurai
1
,
Yasufumi Katanasaka
1
,
Yusuke Miyazaki
1
,
Tomohiro Asakawa
2
,
Toshiyuki Kan
2
,
Junya Inagaki
3
,
Hiromichi Wada
4
,
Koji Hasegawa
4
,
Tatsuya Morimoto
1
Affiliations
1
Division of Molecular Medicine, School of Pharmaceutical Sciences - University of Shizuoka.
2
Synthetic Organic & Medicinal Chemistry, School of Pharmaceutical Sciences - University of Shizuoka.
3
Department of Diabetes and Clinical Nutrition, Graduate School of Medicine - Kyoto University.
4
Division of Translational Research, Clinical Research Institute - Kyoto Medical Center.
PMID:
30416575
PMCID:
PMC6213126
DOI:
10.15420/ecr.2017:23:14
No abstract available
Keywords:
Hypertrophy; heart failure; natural product.